How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

1 day ago
Bioprocess,Biomanufacturing,News

How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

1 day ago

Clinical Operations: Biggest Challenges Facing the Industry in 2020

I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...

3 days ago
Clinical Development,Clinical Operations,News

Clinical Operations: Biggest Challenges Facing the Industry in 2020

I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...

3 days ago

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

1 week ago
Oncology,R&D,Biology,News

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

1 week ago

Trending Innovations in Cold Chain Processes

As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....

2 weeks ago
Bioprocess,Biomanufacturing,CMC,News

Trending Innovations in Cold Chain Processes

As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....

2 weeks ago

How Can We Speed up Vaccine R&D?

With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...

3 weeks ago
R&D,Biology,News

How Can We Speed up Vaccine R&D?

With the rapid spread of the coronavirus 2019-nCoV through China and now globally, governments and organisations have implemented a range of preventative measures. Chinese provinces including Beijing and Shanghai have shut down long-distance bus services and entirely closed off some...

3 weeks ago

Weekly News Round-up – 24/1/20

The World Health Organisation (WHO) has been in the news a lot this week, a fact that doesn't often herald good news. The first, of course, was to discuss the outbreak of a new coronavirus in China, against which no antidote...

4 weeks ago
Weekly Roundups,News

Weekly News Round-up – 24/1/20

The World Health Organisation (WHO) has been in the news a lot this week, a fact that doesn't often herald good news. The first, of course, was to discuss the outbreak of a new coronavirus in China, against which no antidote...

4 weeks ago

Avoiding Bias in Precision Medicine

Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...

1 month ago
R&D,Clinical Development,Clinical Operations,Race and Ethics,Precision and Personalised Medicine,News

Avoiding Bias in Precision Medicine

Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...

1 month ago

The Future of Organ-on-a-Chip

Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....

1 month ago
Oncology,R&D,Biology,News

The Future of Organ-on-a-Chip

Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....

1 month ago

Time to invest in CGT: Its Benefits for Pharma

The concept of cell and gene therapy (CGT), wherein scientists and healthcare experts adapt cells and genes to treat illnesses, is nothing new in the life science space. Even the relatively new CRISPR has transformed into a household buzzword over...

5 months ago
Bioprocess,CGT,News

Time to invest in CGT: Its Benefits for Pharma

The concept of cell and gene therapy (CGT), wherein scientists and healthcare experts adapt cells and genes to treat illnesses, is nothing new in the life science space. Even the relatively new CRISPR has transformed into a household buzzword over...

5 months ago

Single-Use Technologies: Challenges and Solutions

Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...

5 months ago
Bioprocess,Biomanufacturing,CMC,News

Single-Use Technologies: Challenges and Solutions

Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...

5 months ago